Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Zuberbier

Showing results (71-80 of 423) with videos related to

Pageof 43
Sort By:
The World Allergy Organization Journal|December 27, 2012
Effects of a Novel GA(2)LEN Training Program on Urticaria on the Knowledge of General Practitioners in Saudi-ArabiaMarcus Maurer, Carsten Bindslev-Jensen, Nicole Schoepke, et al.
Allergo Journal International|February 21, 2017
A novel experimental technology for testing efficacy of air purifiers on pollen reductionKarl-Christian Bergmann, Torsten Sehlinger, Julia Gildemeister, et al.
Expert Opinion on Pharmacotherapy|February 27, 2016
Current and future therapies for treating chronic spontaneous urticariaMarcus Maurer, Gino A Vena, Nicoletta Cassano, et al.
Allergo Journal International|July 19, 2021
Face masks suitable for preventing COVID-19 and pollen allergy. A study in the exposure chamberKarl-Christian Bergmann, Sebastian Kugler, Torsten Zuberbier, et al.
Allergo Journal : Interdisziplinare Zeitschrift Fur Allergologie Und Umweltmedizin : Organ Der Deutschen Gesellschaft Fur Allergie- Und Immunitatsforschung|August 16, 2021
Karl-Christian Bergmann, Sebastian Kugler, Torsten Zuberbier, et al.
Journal of Investigational Allergology & Clinical Immunology|August 21, 2003
Immunophenotypic characterization of peripheral B cells. During short-term immunotherapy with tree pollen allergoid and the immunoadjuvant monophosphoryl lipid AAnne C Röver, Sascha Reimann, Torsten Zuberbier, et al.
Current Opinion in Allergy and Clinical Immunology|May 25, 2017
Alternative treatments for chronic spontaneous urticaria beyond the guideline algorithmGino A Vena, Marcus Maurer, Nicoletta Cassano, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 12, 2006
Sublingual immunotherapyLucie Heinzerling, Margitta Worm, Karl-Christian Bergmann, et al.
The Journal of Allergy and Clinical Immunology|February 10, 2009
High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover studyFrank Siebenhaar, Franziska Degener, Torsten Zuberbier, et al.
Experimental Dermatology|October 2, 2014
Skin mast cells develop non-synchronized changes in typical lineage characteristics upon cultureSven Guhl, Angelos Neou, Metin Artuc, et al.
Pageof 43

Showing results (71-80 of 423) with videos related to

Sort By:
Pageof 43
The World Allergy Organization Journal|December 27, 2012
Effects of a Novel GA(2)LEN Training Program on Urticaria on the Knowledge of General Practitioners in Saudi-ArabiaMarcus Maurer, Carsten Bindslev-Jensen, Nicole Schoepke, et al.
Allergo Journal International|February 21, 2017
A novel experimental technology for testing efficacy of air purifiers on pollen reductionKarl-Christian Bergmann, Torsten Sehlinger, Julia Gildemeister, et al.
Expert Opinion on Pharmacotherapy|February 27, 2016
Current and future therapies for treating chronic spontaneous urticariaMarcus Maurer, Gino A Vena, Nicoletta Cassano, et al.
Allergo Journal International|July 19, 2021
Face masks suitable for preventing COVID-19 and pollen allergy. A study in the exposure chamberKarl-Christian Bergmann, Sebastian Kugler, Torsten Zuberbier, et al.
Allergo Journal : Interdisziplinare Zeitschrift Fur Allergologie Und Umweltmedizin : Organ Der Deutschen Gesellschaft Fur Allergie- Und Immunitatsforschung|August 16, 2021
Karl-Christian Bergmann, Sebastian Kugler, Torsten Zuberbier, et al.
Journal of Investigational Allergology & Clinical Immunology|August 21, 2003
Immunophenotypic characterization of peripheral B cells. During short-term immunotherapy with tree pollen allergoid and the immunoadjuvant monophosphoryl lipid AAnne C Röver, Sascha Reimann, Torsten Zuberbier, et al.
Current Opinion in Allergy and Clinical Immunology|May 25, 2017
Alternative treatments for chronic spontaneous urticaria beyond the guideline algorithmGino A Vena, Marcus Maurer, Nicoletta Cassano, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 12, 2006
Sublingual immunotherapyLucie Heinzerling, Margitta Worm, Karl-Christian Bergmann, et al.
The Journal of Allergy and Clinical Immunology|February 10, 2009
High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover studyFrank Siebenhaar, Franziska Degener, Torsten Zuberbier, et al.
Experimental Dermatology|October 2, 2014
Skin mast cells develop non-synchronized changes in typical lineage characteristics upon cultureSven Guhl, Angelos Neou, Metin Artuc, et al.
Pageof 43